Me.
Medical Device : Personalised Monitoring
The menopause is a condition that affects 50% of the world's population with a significant impact on health, wellbeing, work and relationships. Yet typically lacks the attention paid to other clinical conditions. Me uses real-time hormone measurement to not only allow users to accurately self-manage their hormone levels at home, but also, critically, to provide the information to users about their hormone levels in real time. This allows users to understand their individual connection to their symptoms, demystifying and enabling greater targeted and accurate medication, self-help and action.
Date of Launch
after 2025
Development Time
Confidential
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Consumers / Users